The pre-GAP-related domain of neurofibromin regulates cell migration through the LIM kinase/cofilin pathway

Molecular and Cellular Neuroscience

Volumn 42, Issue 4, 2009, Pages 278-287

  Starinsky Elbaz, Sigal ^a   Faigenbloom, Lior ^a   Friedman, Eitan ^a,b   Stein, Reuven ^a   Kloog, Yoel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

GAP related domain; LIM kinase cofilin pathway; Neurofibromatosis type 1; Neurofibromin; Pre GRD function

Indexed keywords

COFILIN; F ACTIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LIM KINASE; NEUROFIBROMIN; P21 ACTIVATED KINASE 1; PHOSPHOPROTEIN; RAC1 PROTEIN; RAS PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; CANCER INVASION; CELL ADHESION; CELL CYCLE REGULATION; CELL FUNCTION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOSKELETON; EMBRYO; FIBROBLAST; FOCAL ADHESION; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMAN; HUMAN CELL; MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA ISOLATION; SIGNAL TRANSDUCTION; STRESS FIBER; TUMOR GROWTH;

ACTIN DEPOLYMERIZING FACTORS; ANIMALS; CELL LINE; CELL MOVEMENT; FIBROBLASTS; FOCAL ADHESIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMANS; LIM KINASES; MICE; MICE, KNOCKOUT; NEUROFIBROMIN 1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P21-ACTIVATED KINASES; PROTEIN STRUCTURE, TERTIARY; RAC1 GTP-BINDING PROTEIN; RAS PROTEINS; RECOMBINANT FUSION PROTEINS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 70350749407     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2009.07.014     Document Type: Article

References (35)

1. Ballester R., Marchuk D., Boguski M., Saulino A., Letcher R., Wigler M., and Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63 (1990) 851-859
2. Barkan B., Starinsky S., Friedman E., Stein R., and Kloog Y. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1. Clin. Cancer Res. 12 (2006) 5533-5542
3. Benard V., Bohl B.P., and Bokoch G.M. Characterization of Rac and Cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J. Biol. Chem. 274 (1999) 13198-13204
4. Bernards A., and Settleman J. GAP control: regulating the regulators of small GTPases. Trends Cell Biol. 14 (2004) 377-385
5. Bornkamm G.W., Berens C., Kuklik-Roos C., Bechet J.M., Laux G., Bachl J., Korndoerfer M., Schlee M., Holzel M., Malamoussi A., Chapman R.D., Nimmerjahn F., Mautner J., Hillen W., Bujard H., and Feuillard J. Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res. 33 (2005) e137
6. Bourne H.R., Sanders D.A., and McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348 (1990) 125-132
7. Buchberg A.M., Cleveland L.S., Jenkins N.A., and Copeland N.G. Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. Nature 347 (1990) 291-294
8. Cichowski K., and Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104 (2001) 593-604
9. Cichowski K., Santiago S., Jardim M., Johnson B.W., and Jacks T. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev. 17 (2003) 449-454
10. Corral T., Jimenez M., Hernandez-Munoz I., Perez de Castro I., and Pellicer A. NF1 modulates the effects of Ras oncogenes: evidence of other NF1 function besides its GAP activity. J. Cell. Physiol. 197 (2003) 214-224
11. de Rooij J., and Bos J.L. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14 (1997) 623-625
12. Edwards D.C., Sanders L.C., Bokoch G.M., and Gill G.N. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat. Cell Biol. 1 (1999) 253-259
13. Elad G., Paz A., Haklai R., Marciano D., Cox A., and Kloog Y. Targeting of K-Ras 4B by S-trans,trans-farnesyl thiosalicylic acid. Biochim. Biophys. Acta 1452 (1999) 228-242
14. Etienne-Manneville S. In vitro assay of primary astrocyte migration as a tool to study Rho GTPase function in cell polarization. Methods Enzymol. 406 (2006) 565-578
15. Fahsold R., Hoffmeyer S., Mischung C., Gille C., Ehlers C., Kucukceylan N., Abdel-Nour M., Gewies A., Peters H., Kaufmann D., Buske A., Tinschert S., and Nurnberg P. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am. J. Hum. Genet. 66 (2000) 790-818
16. Fiordalisi J.J., Keller P.J., and Cox A.D. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res. 66 (2006) 3153-3161
17. Hannan F., Ho I., Tong J.J., Zhu Y., Nurnberg P., and Zhong Y. Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras. Hum. Mol. Genet. 15 (2006) 1087-1098
18. -/- cells. J. Biol. Chem. 276 (2001) 7240-7245
19. Ingram D.A., Yang F.C., Travers J.B., Wenning M.J., Hiatt K., New S., Hood A., Shannon K., Williams D.A., and Clapp D.W. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J. Exp. Med. 191 (2000) 181-188
20. Ishizaki T., Naito M., Fujisawa K., Maekawa M., Watanabe N., Saito Y., and Narumiya S. p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett. 404 (1997) 118-124
21. Korf B.R. Plexiform neurofibromas. Am. J. Med. Genet. 89 (1999) 31-37
22. Lau N., Feldkamp M.M., Roncari L., Loehr A.H., Shannon P., Gutmann D.H., and Guha A. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J. Neuropathol. Exp. Neurol. 59 (2000) 759-767
23. Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A., Obinata T., Ohashi K., Mizuno K., and Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285 (1999) 895-898
24. Mahgoub N., Taylor B.R., Gratiot M., Kohl N.E., Gibbs J.B., Jacks T., and Shannon K.M. In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells. Blood 94 (1999) 2469-2476
25. Mangoura D., Sun Y., Li C., Singh D., Gutmann D.H., Flores A., Ahmed M., and Vallianatos G. Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene 25 (2006) 735-745
26. Marchuk D.A., Saulino A.M., Tavakkol R., Swaroop M., Wallace M.R., Andersen L.B., Mitchell A.L., Gutmann D.H., Boguski M., and Collins F.S. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11 (1991) 931-940
27. Marom M., Haklai R., Ben-Baruch G., Marciano D., Egozi Y., and Kloog Y. Selective inhibition of Ras-dependent cell growth by farnesylthiosalicylic acid. J. Biol. Chem. 270 (1995) 22263-22270
28. Martin G.A., Viskochil D., Bollag G., McCabe P.C., Crosier W.J., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R.M., et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63 (1990) 843-849
29. Ozawa T., Araki N., Yunoue S., Tokuo H., Feng L., Patrakitkomjorn S., Hara T., Ichikawa Y., Matsumoto K., Fujii K., and Saya H. The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. J. Biol. Chem. 280 (2005) 39524-39533
30. Pollard T.D., and Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112 (2003) 453-465
31. Raftopoulou M., and Hall A. Cell migration: Rho GTPases lead the way. Dev. Biol. 265 (2004) 23-32
32. Riccardi V.M. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. 2nd Ed (1992), John Hopkins University Press, Baltimore
33. Scott R.W., and Olson M.F. LIM kinases: function, regulation and association with human disease. J. Mol. Med. 85 (2007) 555-568
34. Shapira S., Barkan B., Friedman E., Kloog Y., and Stein R. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways. Cell Death Differ. 14 (2007) 895-906
35. Yan J., Chen S., Zhang Y., Li X., Li Y., Wu X., Yuan J., Robling A.G., Kapur R., Chan R.J., and Yang F.C. Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1. Hum. Mol. Genet. 17 (2008) 936-948